Cidara axes 30% of staff to focus on flu prevention drug
The company plans to focus its resources on conducting clinical trials for CD388 influenza prevention therapy.
The company plans to focus its resources on conducting clinical trials for CD388 influenza prevention therapy.
What's Your Reaction?
